1

The Big Picture:Delivering Strategy 2020

Mark Wilson

25th September 2014

Strategy to 2020

Vision Mission

Our Vision is a world of improved healthwhere decisions about health and health care are informed by high-

quality, relevant and up-to-date synthesized research evidence.

Our Mission is to promote evidence-informed health decision-making

by producing high-quality, relevant, accessible systematic reviews and other synthesized research evidence.

Vision Mission Goals

Goal 1: Producing Evidence - To produce high-quality, relevant, up-to-date systematic reviews and other synthesized research evidence to inform health decision-making

Goal 2: Accessible Evidence - To make Cochrane evidence accessible and useful to everybody, everywhere in the world

Strategy to 2020

Goal 3: Advocating for Evidence - To make Cochrane the ‘home of evidence’ to inform health decision-making, build greater recognition of our work, and become the leading advocate for evidence-informed health care.

Goal 4: Building an Effective & Sustainable Organisation - To be a diverse, inclusive and transparent international organisation that effectively harnesses the enthusiasm and skills of our contributors, is guided by our principles, governed accountably, managed efficiently and makes optimal use of its resources.

Objectives

Objective 1 of 7:

We will continue to develop and implement comprehensive quality

assurance mechanisms for editorial and methodological

standards throughout our production and updating

processes.

Goal One: Producing Evidence

Strategy to 2020 Vision Mission Goals Objectives

Strategy to 2020 Vision Mission Goals Objectives

Goal One7

Objectives

Goal Three

8 Objectives

Goal Four7

Objectives

Goal Two6

Objectives

Vision Mission Goals Objectives Targets

2014 Target: High Quality

Goal One: Producing Evidence

Objectives

Create a prioritised set of the existing MECIR standards with the aim of

achieving 100% compliance to them for new Cochrane Systematic Reviews.

9

Delivering Strategy to 2020

Vision Mission Goals Objectives Targets

4 Goals

28 Objectives

21 Targets for 2014

11

Delivering Strategy to 2020

http://www.cochrane.org/community/organisation-administration/cochrane-strategy-2020

Create a prioritised set of the existing MECIR standards with the aim of

achieving 100% compliance to them for new Cochrane Systematic Reviews.

• Quality assurance process has been highly successful and continued due to demand

• An audit process has now also started which will lead to the development of the subset

Vision Mission Goals Objectives Targets

Target 1.2: MECIR subset

Goal One: Producing Evidence

Objectives

Objectives

Vision Mission Goals Objectives Targets

Improve production processes by implementing a web-based author

support tool

• Decision made on preferred provider following RFP process

• Implementation work will start immediately with anticipated full launch in Spring 2015

Target 1.3.i: Author Support Tool

Goal One: Producing Evidence

Vision Mission Goals Objectives Targets

Objectives

Develop a roadmap for achieving universal open access to new and

updated Cochrane Systematic Reviews by the end of 2016.

• Significant work has been undertaken to scope out possible models for Cochrane

• A recommendation to explore two specific models in detail is being considered by the Steering Group

• Open Access roadmap will be in place in early 2015

Target 2.4: Open Access Roadmap

Goal Two: Accessible Evidence

Vision Mission Goals Objectives Targets

Objectives

Goal Two: Accessible Evidence

Finalise strategy, establish an integrated translation management system and introduce key digital content and multi-lingual portals in French, Spanish and three other languages.

• Strategy approved and translation co-ordinator appointed

• Translation Management System adopted and already in use by 12 language teams – with many more to come

• €400,000 raised for translation into German & East European languages

• Multi-lingual web sites to be launched in 2015

Target 2.6: Translation Strategy

Vision Mission Goals Objectives Targets

Objectives

Goal Three: Advocating for Evidence

Create a coherent Cochrane brand across all content.

• New logo approved• Full launch of new brand on

schedule for Jan 2015

Target 3.1: Coherent Brand

Our new logo

Our strapline:

Trusted evidence. Informed decisions. Better health.

Cochrane Library

The only sub brand that will use the main brand colours

Our colours

Master brand colours

Sub brand colours

How does it look? Initial mock-ups

Cochrane Groups

How do they look? Initial report designs

Key milestones

October November December January February March

Launch planning

Use of new master brand

Launch of sub brands

31 January

31 January – 31 March

Vision Mission Goals Objectives Targets

Objectives

Goal Three: Advocating for Evidence

Identify and establish partnerships with three to five international

strategic stakeholders to advance evidence-informed health decision-

making.

• GIN and Wikipedia partnerships formed

• Campbell Collaboration partnership imminent

• Will begin working on new Cochrane-WHO work plan 2015-

Target 3.2: Establish 3-5 strategic partnerships

Vision Mission Goals Objectives Targets

Objectives

Goal Four: Building an Effective and Sustainable Organisation

Develop, and begin implementation of, an inter-professional and inclusive

training and professional development strategy.

• Training strategy approved• Implementation to start by the end

of the year

Target 4.2: Training Strategy

Vision Mission Goals Objectives Targets

Objectives

Goal Four: Building an Effective and Sustainable Organisation

We will increase the transparency of the organisation’s governance and improve the opportunities for any

contributor to participate in governing …

• Initial paper to frame review with the Cochrane Steering Group (CSG)

• CSG have undertaken a board development day

Target 4.3: Governance review

Vision Mission Goals Objectives Targets

Objectives

Learning As We Go

Gather systematic data and improve our understanding of end-user

experience and need; and establish a framework for ongoing reassessment.

• Critical to informing our future development

• Larger scope than anticipated, so we have deferred the deadline to ensure it is done properly

Target 2.1: User Experience Review and Framework

29

The Big Picture (1)

2014 – Overall, an excellent foundational year on delivering Strategy to 2020;2015 will see more tangible change and impact: • A lot is being taken on and the Strategy must be a strategy owned

and delivered by the whole organisation – not just the CET• A marathon not a sprint! We can adjust our speed of change and

need to ensure we deliver those initial targets we have set• Planning & Initial Implementation Phase: Extensive Consultation &

Engagement inside Cochrane in 2014:• High/Ongoing for 6 targets: (1.1) Prioritization; (2.6) Translation; (3.1) Cochrane brand;

(4.2) Training & Development; (4.4) CRG/Centres & Branches/Fields/Consumers & Methods Groups Reviews

• Medium &/or will Increase for 5 targets: (1.4) Non-Standard Methods; (2.2) Dissemination Checklist; (2.4) Open Access; (3.4) Global impact stories; (4.3) Governance Review

30

The Big Picture (2)

• In 2015 wide consultation/planning needed for 5 targets: (1.3ii) Review Reduction Time; (2.1) User Experience; (2.5) Simplified/Standardized Language; (3.3) Global Policy/Advocacy framework & positioning; (4.1) Membership scheme

2015 Finalisation/Implementation Roll-Out: (Goal 1) Prioritization; MECIR subset; CAST implementation; Non-Standard Methods strategy; (Goal 2) Dissemination plans in Reviews; Translation; (Goal 3) Cochrane branding; (Goal 4) Training & Development; Cochrane Steering Group reform

31

The Big Picture (3)

• Cochrane continuing to grow– Nearly 35,000 registered volunteers; with over 8,000 active in the last six

months– Four new Cochrane branches approved/opened: Japan, Malaysia, Mexico,

Portugal; and French Satellite of the Musculoskeletal CRG opened

• Cochrane Library Sales– Record year in 2013-14 for sales revenues and royalties– Sales on target - 5% increase in 2014 projected;

• Very Strong financial position– Excellent 2013-14 results: £1.2m operating surplus; – Reserves at record £7.2m; – Expenditure/Run Rate 67% - well below budget.

• Thanks to all collaborators for their efforts this year